People

  1. Vanoli
    Vanoli
  2. Teitcher
    Teitcher
  3. Tortora
    Tortora
  4. Pavletich
    Pavletich
  5. Wills
    Wills
  6. Featherstone
    Featherstone
  7. Haeggstroem
    Haeggstroem
  8. Jacobs
    Jacobs
  9. Carlo
    Carlo
  10. Dalbagni
    Dalbagni
  11. Gorelick
    Gorelick
  12. Sanghvi
    Sanghvi
  13. Langenbacher
    Langenbacher
  14. Mendelsohn
    Mendelsohn
  15. Anopa
    Anopa

Recent Works

  1. Patient-centered outcomes in ARIEL3, a phase 3, randomized, placebo-controlled study of rucaparib maintenance treatment in patients with recurrent ovarian carcinoma
    Meeting Abstract

    Bedel, D. J.; Lorusso, D.; Aghajanian, C.; Oaknin, A.; Dean, A.; Colombo, N.; Weberpals, J. I.; Clamp, A. R.; Scambia, G.; Leary, A.; more...
    Value in Health (2019)

    Fulltext@MSK | Save
  2. Cost-effectiveness of a 24-month fixed duration of venetoclax in combination with rituximab in relapsed or refractory chronic lymphocytic leukemia in the United States
    Meeting Abstract

    Huntington, S. F.; Strunz-McKendry, T.; Masaquel, A. S.; Shapouri, S.; Sail, K.; Durno, N.; Mato, A.
    Value in Health (2019)

    Fulltext@MSK | Save
  3. Quality adjusted time without symptoms of disease progression or toxicity (Q-TWIST) of nivolumab plus ipilimumab (NIVO+IPI) vs sunitinib (SUN) among untreated advanced renal cell carcinoma (ARCC) patients (patients) with intermediate or poor prognostic risk
    Meeting Abstract

    Shah, R.; Botteman, M.; Kwon, Y.; Gooden, K. M.; Cella, D.; Motzer, R.
    Value in Health (2019)

    Fulltext@MSK | Save